S. Hill

发表

Reduced thermal sensitivity of the vasculature in a slowly growing tumour.

J. Denekamp, K. Smith, S. Hill, 1989, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Hyperthermia treatment of experimental tumors.

F. Stewart, J. Denekamp, S. Hill, 1981, Henry Ford Hospital medical journal.

Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy.

Borivoj Vojnovic, B. Vojnovic, S. Ameer-Beg, 2005, Advanced drug delivery reviews.

Measurement of tumor oxygenation: a comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor.

B. Vojnovic, P. Wardman, D. Chaplin, 1997, Radiation research.

Vascular effects dominate solid tumor response to treatment with combretastatin A‐4‐phosphate

C. Kanthou, C. Reyes-Aldasoro, G. Tozer, 2011, International journal of cancer.

Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action.

J. Denekamp, S. Hill, K. Williams, 1989, European journal of cancer & clinical oncology.

Vinca alkaloids: anti-vascular effects in a murine tumour.

J. Denekamp, D. Chaplin, S. Hill, 1993, European journal of cancer.

Anti—vascular approaches to solid tumour therapy: Evaluation of vinblastine and flavone acetic acid

D. Chaplin, S. Hill, L. E. Sampson, 1995, International journal of cancer.

Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate.

D. Chaplin, S. Hill, G. Pettit, 1999, Anticancer research.

Synergy between vascular targeting agents and antibody-directed therapy.

R. Pedley, J. Raleigh, S. Hill, 2002, International journal of radiation oncology, biology, physics.

ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.

D. Blakey, M. Stratford, G. Tozer, 2002, Cancer research.

Preclinical evaluation of the antitumour activity of the novel vascular targeting agent Oxi 4503.

D. Chaplin, S. Hill, G. Pettit, 2002, Anticancer research.

Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models

G. Tozer, D. Chaplin, S. Hill, 2002, International journal of cancer.

Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation.

C. Grau, J. Overgaard, M. Horsman, 1994, International journal of radiation oncology, biology, physics.

Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours.

S. Hill, D. Chaplin, DJ Chaplin, 1995, British Journal of Cancer.

VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice.

R. Muschel, E. Savory, P. Allen, 2013, Blood.

G‐CSF rescues tumor growth and neo‐angiogenesis during liver metastasis under host angiopoietin‐2 deficiency

M. Brady, H. Augustin, W. Fu, 2013, International journal of cancer.

The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen.

P. Hoskin, S. Hill, M. Saunders, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The development of combretastatin A4 phosphate as a vascular targeting agent.

D. Chaplin, S. Hill, 2002, International journal of radiation oncology, biology, physics.

Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.

J. Fowler, S. Hill, 1977, British Journal of Cancer.

The effect of vinca alkaloids on tumour blood flow.

J. Denekamp, D. Chaplin, S. Hill, 1994, Advances in experimental medicine and biology.

The response of six mouse tumours to combined heat and X rays: implications for therapy.

J. Denekamp, S. Hill, 1979, The British journal of radiology.

Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation.

J. Fowler, B. Dubray, H. Thames, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The effect of vascular occlusion on the thermal sensitization of a mouse tumour.

J. Denekamp, S. Hill, 1978, The British journal of radiology.

Angiogenic attack as a therapeutic strategy for cancer.

J. Denekamp, S. Hill, S. Hill, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Potent anti-metastatic activity of combretastatin-A4.

R. Hesketh, K. Brindle, D. Beauregard, 2001, International journal of oncology.

Human tumor blood flow is enhanced by nicotinamide and carbogen breathing.

P. Hoskin, S. Hill, M. Saunders, 1997, Cancer research.

Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.

J. Overgaard, M. Horsman, A. Khalil, 1994, Acta oncologica.

A comparison of vascular-mediated tumor cell death by the necrotizing agents GR63178 and flavone acetic acid.

J. Denekamp, S. Hill, K. Williams, 1992, International journal of radiation oncology, biology, physics.

Studies with a panel of tumours having a variable sensitivity to FAA, to investigate its mechanism of action.

J. Denekamp, S. Hill, K. Williams, 1991, International journal of radiation biology.

Ischaemia induced cell death in tumors: importance of temperature and pH.

M. Horsman, D. Chaplin, S. Hill, 1994, International journal of radiation oncology, biology, physics.

Radioprotection by pentobarbitone sodium of a murine tumour in vivo.

S. Hill, J. Moulder, P. Sheldon, 1977, International journal of radiation biology and related studies in physics, chemistry, and medicine.

Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice.

J. Fowler, A. Begg, S. Hill, 1975, International journal of radiation biology and related studies in physics, chemistry, and medicine.

Relative effectiveness of 12-hourly fractionation and a non-uniform x-ray schedule in the optimum fractionation of C3H mouse mammary tumours.

J. Fowler, S. Hill, P. Sheldon, 1975, The British journal of radiology.

Stromal sensitivity to radiation and hyperthermia.

J. Denekamp, K. Smith, S. Hill, 1987, British Journal of Cancer.

Does local tumour heating im mice influence metastatic spread?

J. Denekamp, S. Hill, 1982, The British journal of radiology.

Chemopotentiation in vivo: no loss of sensitization with fractionation.

S. Hill, D. Siemann, 1984, British Journal of Cancer.

c Measurement of Tumor Oxygenation PRECLINICAL EVALUATION OF THE NOVEL HYPOXIC MARKER 99m Tc-HL91 (PROGNOX) IN MURINE AND XENOGRAFT SYSTEMS IN VIVO

D. Chaplin, S. Hill, D. Honess, 1998 .

Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxia

D. Chaplin, S. Hill, D. Collingridge, 2001, British Journal of Cancer.

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours.

A. C. Begg, A. Begg, J. Denekamp, 1988, British Journal of Cancer.

Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration.

J. Fowler, J. Denekamp, M. Stratford, 1983, International journal of radiation biology and related studies in physics, chemistry, and medicine.

The biology of the combretastatins as tumour vascular targeting agents

C. Kanthou, G. Tozer, S. Hill, 2002, International journal of experimental pathology.

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

G. Tozer, D. Chaplin, S. Hill, 1997, Cancer research.

An investigation of the pharmacokinetics of topical terbinafine (Lamisil®) 1% cream

A. Finlay, S. Hill, R. Thomas, 1992, The British journal of dermatology.

Protocols forstability testing

K. A. Khan, S. Hill, 1981 .

Effect of terbinafine on the pharmacokinetics of cyclosporin in humans.

A. Finlay, S. Hill, C. Long, 1994, The Journal of investigative dermatology.

Pharmacokinetics of parenterally administered amoxycillin.

S. Hill, K. H. Jones, L. Lees, 1980, The Journal of infection.

Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors.

Christiana Ruhrberg, Chryso Kanthou, Constantino C Reyes-Aldasoro, 2008, Cancer research.

The fractionated response of mouse stroma after X-rays and neutrons: influence of early vs late expression of damage.

J. Denekamp, K. Smith, S. Hill, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Vascular occlusion and tumour cell death.

J. Denekamp, S. Hill, B. Hobson, 1983, European journal of cancer & clinical oncology.

nitrosourea in the Absence or Presence of Misonidazole in Mice 1

P. Keng, S. Hill, D. Siemann, 2006 .

In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.

P. Keng, S. Hill, D. Siemann, 1985, Cancer research.

Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice.

Lei Zhao, Jeffrey W Pollard, J. Pollard, 2012, Blood.

Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.

R. Muschel, J. Im, E. Fokas, 2012, Cancer research.

Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.

D. Chaplin, S. Hill, C. Parkins, 1996, The British journal of cancer. Supplement.

Pharmacokinetics of drug infusions

S. Hill, Sa Hill, 2004 .

Modification of tumor blood flow: current status and future directions.

G M Tozer, G. Tozer, D. Chaplin, 1998, Seminars in radiation oncology.

The Control of Tumour Oxygenation in Mice: The Importance of Tumour Site

D. Hirst, S. Hill, 1990 .

An experimental study of tumour size and radiosensitivity: analysis by regrowth delay.

J. Denekamp, S. Hill, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

An experimental study of tumour size and analysis by regrowth delay

J. Denekamp, S. Hill, 1989 .

Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma: I. Clinical and vascular studies.

J. Denekamp, G. Rustin, S. Hill, 1993, British Journal of Cancer.

Enhancement of vascular targeting by inhibitors of nitric oxide synthase.

G. Tozer, M. Naylor, P. Davis, 2002, International journal of radiation oncology, biology, physics.

Tumour vascular disrupting agents: combating treatment resistance.

G M Tozer, C. Kanthou, B. Vojnovic, 2008, The British journal of radiology.

The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability.

K. Brindle, D. Beauregard, D. Chaplin, 2001, Cancer research.

Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status.

K. Brindle, P. Thelwall, G. Adams, 1998, British Journal of Cancer.

The influence of pre-treatment temperature on the thermal sensitivity of a mouse tumour.

J. Denekamp, K. Smith, M. Joiner, 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.

Enhanced tumor responses through therapies combining CCNU, MISO and radiation.

S. Hill, D. Siemann, 1984, International Journal of Radiation Oncology, Biology, Physics.

Increased therapeutic benefit through the addition of misonidazole to a nitrosourea-radiation combination.

S. Hill, D. Siemann, 1986, Cancer research.

Comparison of tumour cure (local control) with regrowth delay in mice.

J. Fowler, S. Hill, P. Sheldon, 1980 .

The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.

P. Keng, S. Hill, D. Siemann, 1984, International journal of radiation oncology, biology, physics.

Tumour radiosensitization by high-oxygen-content gases: influence of the carbon dioxide content of the inspired gas on PO2, microcirculatory function and radiosensitivity.

B Vojnovic, B. Vojnovic, D. Chaplin, 1998, International journal of radiation oncology, biology, physics.

Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.

R. Pedley, D. Chaplin, R. Begent, 2001, Cancer research.

Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.

S. Hill, P. Sheldon, 1977, British Journal of Cancer.

Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.

J. Fowler, S. Hill, P. Sheldon, 1976, The British journal of radiology.

Effect of carbogen breathing on tumour microregional blood flow in humans.

P. Hoskin, S. Hill, P J Hoskin, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down.

Ethaar El-Emir, R. Maxwell, U. Qureshi, 2007, International journal of oncology.

Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts

M A Konerding, J. Denekamp, M. Presta, 1999, British Journal of Cancer.

Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect

A. Harris, B. Slotman, R. Muschel, 2016, Oncotarget.

The effect of BW12C on the radiosensitivity and necrosis of murine tissues and tumours.

G. Stevens, J. Denekamp, M. Joiner, 1994, Australasian radiology.

Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations.

P. Hoskin, S. Hill, P J Hoskin, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypoxia Imaging Using PET and SPECT: The Effects of Anesthetic and Carrier Gas on [64Cu]-ATSM, [99mTc]-HL91 and [18F]-FMISO Tumor Hypoxia Accumulation

Veerle Kersemans, Philip D. Allen, Ruth J. Muschel, 2011, PloS one.

Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses

G. Tozer, S. Hill, V. Prise, 2009, Clinical Cancer Research.

Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.

J. Overgaard, M. Horsman, P. Wood, 1996, The British journal of cancer. Supplement.

The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification

G. Tozer, M. Čemažar, S. Hill, 2005, British Journal of Cancer.

Differential sensitivity of two adenocarcinoma xenografts to the anti‐vascular drugs combretastatin A4 phosphate and 5,6‐dimethylxanthenone‐4‐acetic acid, assessed using MRI and MRS

K. Brindle, D. Beauregard, R. Pedley, 2002, NMR in biomedicine.

Survival in subpopulations of cells derived from solid KHT sarcomas by centrifugal elutriation following treatment with CCNU and MISO.

P. Keng, S. Hill, D. Siemann, 1984, International journal of radiation oncology, biology, physics.

Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.

Veerle Kersemans, Sean Smart, Arkadij M Elizarov, 2010, Nuclear medicine and biology.

Microregional blood flow in murine and human tumours assessed using laser Doppler microprobes.

P. Hoskin, M. Leahy, D. Chaplin, 1996, The British journal of cancer. Supplement.

Determinants of anti-vascular action by combretastatin A-4 phosphate: role of nitric oxide

G. Tozer, D. Chaplin, S. Hill, 2000, British Journal of Cancer.

Actinomycin D and radiation: effects on mouse lung.

J. Denekamp, S. Hill, E. Travis, 1986, European journal of cancer & clinical oncology.

Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.

D. Chaplin, S. Hill, D J Chaplin, 1998, International journal of radiation oncology, biology, physics.

Histology as a method for determining thermal gradients in heated tumours.

J. Denekamp, S. Hill, 1982, The British journal of radiology.

Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry.

D. Chaplin, S. Hill, M. Saunders, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Further investigations of the effects of the hypoxic-cell radiosensitizer, Ro-07-0582, on local control of a mouse tumour.

S. Hill, P. Sheldon, 1977, British Journal of Cancer.

Ischemia reperfusion injury in tumors: the role of oxygen radicals and nitric oxide.

M. Stratford, D. Chaplin, S. Hill, 1995, Cancer research.

Site dependent response of tumours to combined heat and radiation.

J. Denekamp, S. Hill, 1982, The British journal of radiology.